Furthermore, consistent with reduction of csACE2 and viral entry by hMAb159, VeroE6-ACE2 cells preincubated with hMAb159 prior to infection with live SARS-CoV-2 virus exhibited a significant decrease in the number of plaques compared with human IgG1 control (Fig. 5A). The gene discussed is ACE2; the disease is infection.